Riversedge Advisors
ABBV icon

Riversedge Advisors’s AbbVie ABBV Stock Holding History

Riversedge Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.24M Buy
4,748
+82
+2% +$21K 0.15% 62
2026
Q2 		$1.17M Buy
4,666
+65
+1% +$14K 0.15% 60
2026
Q1 		$1M Sell
4,601
-128
-3% -$28.4K 0.16% 57
2025
Q4 		$1.08M Buy
4,729
+200
+4% +$45.6K 0.18% 47
2025
Q3 		$1.05M Buy
4,529
+756
+20% +$154K 0.18% 49
2025
Q2 		$700K Buy
3,773
+96
+3% +$17.8K 0.14% 52
2025
Q1 		$770K Buy
3,677
+38
+1% +$7.39K 0.17% 52
2024
Q4 		$647K Buy
3,639
+84
+2% +$15.4K 0.15% 52
2024
Q3 		$702K Buy
3,555
+85
+2% +$15.9K 0.16% 48
2024
Q2 		$595K Sell
3,470
-9
-0.3% -$1.49K 0.15% 48
2024
Q1 		$633K Buy
3,479
+106
+3% +$18.3K 0.16% 44
2023
Q4 		$523K Sell
3,373
-326
-9% -$47.5K 0.14% 48
2023
Q3 		$551K Buy
3,699
+681
+23% +$100K 0.16% 45
2023
Q2 		$407K Buy
3,018
+4
+0.1% +$587 0.11% 51
2023
Q1 		$480K Buy
3,014
+383
+15% +$58.6K 0.14% 51
2022
Q4 		$425K Buy
2,631
+131
+5% +$20.1K 0.14% 54
2022
Q3 		$336K Hold
2,500
– – 0.12% 60
2022
Q2 		$383K Hold
2,500
– – 0.14% 53
2022
Q1 		$405K Sell
2,500
-58
-2% -$8.42K 0.13% 50
2021
Q4 		$346K Buy
2,558
+58
+2% +$6.85K 0.11% 55
2021
Q3 		$270K Hold
2,500
– – 0.09% 53
2021
Q2 		$282K Hold
2,500
– – 0.1% 44
2021
Q1 		$271K Hold
2,500
– – 0.12% 39
2020
Q4 		$268K Hold
2,500
– – 0.12% 41
2020
Q3 		$219K Hold
2,500
– – 0.12% 44
2020
Q2 		$245K Buy
+2,500
New +$220K 0.14% 36

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Riversedge Advisors's ABBV Position: Q3 2026 in Review

Riversedge Advisors increased its AbbVie (ABBV) stake by 1.8% in Q3 2026, buying an estimated $21K and bringing the position to 4,748 shares worth $1.24M. The position accounts for 0.15% of the portfolio, ranked #62.

Riversedge Advisors first reported a position in ABBV in Q2 2020 and has held it in 26 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Riversedge Advisors held 4,748 shares of AbbVie worth $1.24M as of Q3 2026.
  • Riversedge Advisors bought 82 AbbVie shares in Q3 2026, an estimated $21K.
  • AbbVie made up 0.15% of Riversedge Advisors's portfolio in Q3 2026, its #62 holding.
  • Riversedge Advisors first reported a position in AbbVie in Q2 2020 and has held it in 26 quarters since.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Riversedge Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.